Nestle recalls DiGiorno pizza nationwide following consumer complaint

Nestle USA Inc. of Schaumburg, IL, is recalling almost 14 tons of frozen DiGiorno Crispy Pan Crust pepperoni pizza because of misbranding and undeclared allergens, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The product contains textured soy protein, a known allergen, which is not declared on the product label.

The frozen pepperoni pizza product carton may actually contain frozen three meat pizza, which contains textured soy protein. The pizza products were produced on June 30, 2021. The best-buy date is March of 2022.

“FSIS is concerned that some product may be in consumers’ freezers. Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase,” according to the recall announcement.

Consumers view the labels here and use the following information to determine whether they have the recalled pizza in their homes.

  • 26-oz. carton containing “DIGIORNO PEPPERONI CRISPY PAN CRUST” with lot code 1181510721 and “Best Buy” date of MAR2022 on the label.

The products subject to recall bear establishment number “EST. 1682A” printed inside the USDA mark of inspection. Establishment 1682A is Nation Pizza Products Limited, which is owned by Nestle USA, Inc. These items were shipped to retail locations and distribution centers nationwide.

 The problem was discovered after the firm received a consumer complaint that a three meat pizza was in a carton labeled as pepperoni pizza.

There have been no confirmed reports of adverse allergic reactions related to consumption of the pizza. Anyone concerned about an injury or illness should contact a healthcare provider.

FSIS routinely conducts recall effectiveness checks to verify recalling firms notify their customers of the recall and that steps are taken to make certain that the product is no longer available to consumers. When available, the retail distribution lists will be posted on the FSIS website at www.fsis.usda.gov/recalls.

Consumers with questions about the recall can contact Bonita Cleveland, Consumer Services Manager at Nestle USA, at 800-681-1676 or bonita.cleveland@us.nestle.com.

(To sign up for a free subscription to Food Safety News, click here.)

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Boozin’ All The Way: Goa Edition thumbnail

Boozin’ All The Way: Goa Edition

Goa has emerged as the destination of choice for entrepreneurs interested in crafting new liquor brands. We find out why. Once upon a time, taverns in Goa were where people got together to discuss local sports, village gossip, and down a shot of that preferred Goan drink, feni. Today, Goan taverns still function, but many…
Read More
Polygenic risk scores could improve colorectal cancer screening thumbnail

Polygenic risk scores could improve colorectal cancer screening

Credit: Pixabay/CC0 Public Domain Rates of colorectal cancer are high despite widespread adoption of screening programs in many high-income European countries. Such programs tend to use a one-size-fits-all approach where most people are screened starting from the same age, and no individual factors are considered in organized population screening. Now, based on one of the
Read More
South African foodborne illness spike declared a national disaster thumbnail

South African foodborne illness spike declared a national disaster

The recent rise in foodborne illness in South Africa has been declared a national disaster. Minister of Justice and Constitutional Development Thembi Simelane said a team of health experts will be appointed shortly to a Ministerial Advisory Committee. This committee will develop medium- to long-term prevention measures to curb incidents of foodborne disease in the
Read More
Are genAI-produced visit summaries the future? thumbnail

Are genAI-produced visit summaries the future?

A project at Beth Israel Deaconess Medical Center's new OpenNotes Lab aims to explore the opportunities and challenges of using artificial intelligence to generate patient visit summaries. WHY IT MATTERS The initiative, which will see OpenNotes collaborate with clinical genAI developer Abridge, will study how AI can enable collaboration between patients and clinicians, while advancing
Read More
Index Of News
Total
0
Share